Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Berke

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the American College of Cardiology|April 1, 1989
Importance of balloon size in coronary angioplastyA B Nichols, R Smith, A D Berke, et al.
Blood|August 1, 1988
Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activityJ Owen, K D Friedman, B A Grossman, et al.
The Journal of Clinical Investigation|June 1, 1987
Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activatorJ Owen, K D Friedman, B A Grossman, et al.
American Heart Journal|April 1, 1988
Cinevideodensitometric analysis of the effect of coronary angioplasty on coronary stenotic dimensionsA B Nichols, A D Berke, J Han, et al.
Annals of Internal Medicine|August 15, 1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II TrialE G Bovill, M L Terrin, D C Stump, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the American College of Cardiology|April 1, 1989
Importance of balloon size in coronary angioplastyA B Nichols, R Smith, A D Berke, et al.
Blood|August 1, 1988
Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activityJ Owen, K D Friedman, B A Grossman, et al.
The Journal of Clinical Investigation|June 1, 1987
Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activatorJ Owen, K D Friedman, B A Grossman, et al.
American Heart Journal|April 1, 1988
Cinevideodensitometric analysis of the effect of coronary angioplasty on coronary stenotic dimensionsA B Nichols, A D Berke, J Han, et al.
Annals of Internal Medicine|August 15, 1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II TrialE G Bovill, M L Terrin, D C Stump, et al.
Pageof 1